Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201-995 (Sandostatin): I. An open-label pilot study

Charles Camisa; Thomas M. O’Dorisio; Ronald F. Maceyko; Gretchen E. Schacht; Hagop S. Mekhjian; Brent A. Howe

Contributions

Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201-995 (Sandostatin)

I. An open-label pilot study

Charles Camisa, MD, Thomas M. O’Dorisio, MD, Ronald F. Maceyko, MD, Gretchen E. Schacht, MD, Hagop S. Mekhjian, MD and Brent A. Howe, BS

Cleveland Clinic Journal of Medicine January 1990, 57 (1) 71-76;

Charles Camisa

Department of Dermatology, The Cleveland Clinic Foundation

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Thomas M. O’Dorisio

Department of Internal Medicine, Ohio State University Hospitals, Columbus, Ohio

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ronald F. Maceyko

Department of Dermatology, The Cleveland Clinic Foundation

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gretchen E. Schacht

Department of Internal Medicine, Ohio State University Hospitals, Columbus, Ohio

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hagop S. Mekhjian

Department of Internal Medicine, Ohio State University Hospitals, Columbus, Ohio

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Brent A. Howe

Department of Internal Medicine, Ohio State University Hospitals, Columbus, Ohio

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

Article Information

vol. 57 no. 1 71-76

PubMed

2306870

Published By

Cleveland Clinic Journal of Medicine

Print ISSN

0891-1150

Online ISSN

1939-2869

History

Published online January 1, 1990.

Cited By...

11 Citations
Google Scholar

PreviousNext

In this issue

Cleveland Clinic Journal of Medicine

Vol. 57, Issue 1

1 Jan 1990

Table of Contents
Table of Contents (PDF)
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201-995 (Sandostatin)

Message Subject (Your Name) has sent you a message from Cleveland Clinic Journal of Medicine

Message Body (Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.

Your Personal Message

CAPTCHA

Please verify that you are a real person.

Citation Tools

Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201-995 (Sandostatin)

Charles Camisa, Thomas M. O’Dorisio, Ronald F. Maceyko, Gretchen E. Schacht, Hagop S. Mekhjian, Brent A. Howe

Cleveland Clinic Journal of Medicine Jan 1990, 57 (1) 71-76;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201-995 (Sandostatin)

Charles Camisa, Thomas M. O’Dorisio, Ronald F. Maceyko, Gretchen E. Schacht, Hagop S. Mekhjian, Brent A. Howe

Cleveland Clinic Journal of Medicine Jan 1990, 57 (1) 71-76;

Share This Article:

Tweet Widget

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

Psoriasis
Somatostatin
Somatotropin

Main menu

User menu

Search

Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201-995 (Sandostatin)

I. An open-label pilot study

Article Information

Cited By...

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords

Navigate

Authors & Reviewers